ZARXIO 300 MCG/0.5 ML SYRINGE

filgrastim-sndz
$529.7700per ML

Strength

300 ug/.5mL

Manufacturer

Sandoz Inc.

NDC

61314031810

Classification

Brand Biologic

Dosage Form

INJECTION, SOLUTION

Route

INTRAVENOUS; SUBCUTANEOUS

Last Updated

10/23/2024

Active Ingredients

FILGRASTIM

Approval Type

Biologic (BLA)

FDA Application

BLA125553

On Market Since

3/6/2015

Pharmacological Classes

Granulocyte Colony-Stimulating Factor
Increased Myeloid Cell Production
Leukocyte Growth Factor

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+0.7%